Takeda Announces First-Quarter FY2025 Results With Significant Late-Stage Pipeline Progression

Takeda (TOKYO:4502/NYSE:TAK) today announced earnings results for the first quarter of fiscal year 2025 (three months ended June 30, 2025), with generic erosion of VYVANSE significantly impacting …